Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2012
03/28/2012CN102391171A Novel Substituted 3-Sulfur Indoles
03/28/2012CN101160301B Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
03/27/2012US8143424 Thyroid like compounds
03/27/2012US8143421 Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/27/2012US8143393 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/27/2012US8143300 Inhibitors of cellular necrosis
03/27/2012US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
03/27/2012US8143288 Inhibitors of HCV replication
03/27/2012US8143278 Organic compounds
03/27/2012US8143250 6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
03/27/2012US8143246 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
03/27/2012CA2554642C Bicyclic carbonyl amino derivatives as chemokine receptor antagonists
03/22/2012WO2012037393A1 Piperidinyl-substituted lactams as gpr119 modulators
03/22/2012WO2012037269A1 Substituted bipyridines for use in organic light-emitting devices
03/22/2012WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012035171A2 New compounds
03/22/2012WO2012035124A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
03/22/2012WO2012035123A1 Arylosulfonamides for the treatment of cns diseases
03/22/2012WO2012035057A2 Process for determining the suitability for distribution of a batch of a thiophene-2-carboxamide derivative
03/22/2012WO2012035023A1 Triazine-oxadiazoles
03/22/2012WO2012034960A1 Pyridine compounds for controlling invertebrate pests ii
03/22/2012WO2012034403A1 Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof
03/22/2012WO2012034363A1 Compounds of hedgehog pathway inhibitors, pharmaceutical compositions containing the same and uses thereof
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071654 Aryl aniline derivatives as beta2 adrenergic receptor agonists
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071652 Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof
03/22/2012US20120071651 Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives
03/22/2012US20120071594 Polytriazinyl compounds as flame retardants and light stabilizers
03/22/2012US20120071524 Compounds for treatment of cancer
03/22/2012US20120071514 Benzoxazolone derivatives as aldosterone synthase inhibitors
03/22/2012US20120071512 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/22/2012US20120071489 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
03/22/2012US20120071481 Isoxazole-5-carboxamide derivatives
03/22/2012US20120071480 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
03/22/2012US20120071478 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071476 Morpholinopurine derivatives
03/22/2012US20120071472 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
03/22/2012US20120071467 Amide derivative
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/22/2012CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2812081A1 Triazine-oxadiazoles
03/22/2012CA2811525A1 Piperidinyl-substituted lactams as gpr119 modulators
03/22/2012CA2811080A1 Heterocyclic compound
03/22/2012CA2808246A1 Arylosulfonamides for the treatment of cns diseases
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2431035A1 Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
03/21/2012EP2430019A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
03/21/2012EP2430018A2 Benzoxazolone derivatives as aldosterone symthase inhibitors
03/21/2012EP2430014A1 Antiviral compounds
03/21/2012EP2430012A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2430011A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/21/2012EP2430006A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2430004A2 Novel oxazolidinone derivatives and their use as orexin receptor antagonists
03/21/2012EP2429998A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2429993A1 Inhibitors of human immunodeficiency virus replication
03/21/2012EP2429295A1 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
03/21/2012EP2207775B1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
03/21/2012EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
03/21/2012EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/21/2012EP1984345B9 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/21/2012EP1532142B1 Polypeptide cleavage process
03/21/2012EP1422218B1 Antiviral agent
03/21/2012CN1922148B Pyrazole derivatives as protein kinase modulators
03/21/2012CN102388039A Pyrazole derivatives used as CCR4 receptor antagonists
03/21/2012CN102388032A Substituted piperidines as CCR3 antagonists
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102382065A Aniline substituted quinazoline derivative
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101870693B Bismaleimide containing 1,3,4-oxadiazole structure and preparation method thereof
03/21/2012CN101812058B Indometacin 2-arylmorpholine ethyl, preparation method and application thereof
03/21/2012CN101610751B Prophylactic or therapeutic agent for alopecia
03/21/2012CN101573336B Chemical compounds of pyridine carboxamide used for 11-beta-HSDI inhibitor
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101379048B Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/21/2012CN101258147B Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138347 Quinoline derivatives as PI3 kinase inhibitors
03/20/2012US8138339 Inhibitors of protein kinases
03/20/2012US8138336 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
03/20/2012US8138213 Isoxazoline-substituted benzamide compound and pesticide
03/20/2012US8138206 Piperidine derivative
03/20/2012US8138186 Pyrazole derivatives as sigma receptors antagonists
03/20/2012US8138184 Isoxazole derivatives and pharmaceutical compositions comprising the same
03/20/2012US8138183 Morpholino pyrimidine derivatives used in diseases linked to mTOR kinase and/or PI3K
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012US8138178 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/20/2012US8138177 Benzimidazolone derivatives as CB2 receptor ligands
03/20/2012US8138175 Heterocyclyl compounds
03/20/2012CA2579840C Carboxamide spirolactam cgrp receptor antagonists
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2526026C Furazanobenzimidazoles
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 647